141 related articles for article (PubMed ID: 1477386)
1. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results.
Githui W; Nunn P; Juma E; Karimi F; Brindle R; Kamunyi R; Gathua S; Gicheha C; Morris J; Omwega M
Tuber Lung Dis; 1992 Aug; 73(4):203-9. PubMed ID: 1477386
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
3. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
[TBL] [Abstract][Full Text] [Related]
4. Under-diagnosis of smear-positive pulmonary tuberculosis in Nairobi, Kenya.
Hawken MP; Muhindi DW; Chakaya JM; Bhatt SM; Ng'ang'a LW; Porter JD
Int J Tuberc Lung Dis; 2001 Apr; 5(4):360-3. PubMed ID: 11334255
[TBL] [Abstract][Full Text] [Related]
5. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Tembo G; Machiels L; Bem C; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1993 Feb; 96(1):1-11. PubMed ID: 8429569
[TBL] [Abstract][Full Text] [Related]
6. Aspects of tuberculosis in Africa. 2. The value of microbiology in the management of tuberculosis in Nairobi, Kenya.
Brindle R
Trans R Soc Trop Med Hyg; 1992; 86(5):470-1. PubMed ID: 1475805
[TBL] [Abstract][Full Text] [Related]
7. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007.
Kwange SO; Budambula NL
Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758
[TBL] [Abstract][Full Text] [Related]
9. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality.
Nunn P; Brindle R; Carpenter L; Odhiambo J; Wasunna K; Newnham R; Githui W; Gathua S; Omwega M; McAdam K
Am Rev Respir Dis; 1992 Oct; 146(4):849-54. PubMed ID: 1416409
[TBL] [Abstract][Full Text] [Related]
10. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
11. The new tuberculosis.
De Cock K
Afr Health; 1994 Mar; 16(3):8-10. PubMed ID: 12318774
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
13. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa.
Harries AD; Maher D; Nunn P
Bull World Health Organ; 1998; 76(6):651-62. PubMed ID: 10191561
[TBL] [Abstract][Full Text] [Related]
14. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
[TBL] [Abstract][Full Text] [Related]
15. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn P
Trans R Soc Trop Med Hyg; 1995; 89(1):78-82. PubMed ID: 7747316
[TBL] [Abstract][Full Text] [Related]
16. HIV-associated pulmonary tuberculosis.
Nunn P
Afr Health; 1991 Nov; 14(1):10-1. PubMed ID: 12343452
[TBL] [Abstract][Full Text] [Related]
17. [Bacteriological examination on needle biopsy specimens of cavity and tuberculoma after a short course chemotherapy in initially sputum positive pulmonary tuberculosis patients].
Lu SH; Wang TP; Lü W; Du RH; Wang HX; Wang ZR
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):832-4. PubMed ID: 17327088
[TBL] [Abstract][Full Text] [Related]
18. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
[TBL] [Abstract][Full Text] [Related]
19. A case control study on human immunodeficiency virus-1 (HIV-1) infection as a risk factor for tuberculosis and leprosy in western Kenya.
Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P; Were M
Tuber Lung Dis; 1993 Dec; 74(6):377-81. PubMed ID: 8136490
[TBL] [Abstract][Full Text] [Related]
20. Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995.
Bercion R; Kuaban C
Int J Tuberc Lung Dis; 1997 Apr; 1(2):110-4. PubMed ID: 9441073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
